Literature DB >> 21653621

Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review.

Ann Van den Bruel1, Matthew J Thompson, Tanya Haj-Hassan, Richard Stevens, Henriette Moll, Monica Lakhanpaul, David Mant.   

Abstract

OBJECTIVE: To collate all available evidence on the diagnostic value of laboratory tests for the diagnosis of serious infections in febrile children in ambulatory settings.
DESIGN: Systematic review. DATA SOURCES: Electronic databases, reference tracking, and consultation with experts. STUDY SELECTION: Studies were selected on six criteria: design (studies of diagnostic accuracy or deriving prediction rules), participants (otherwise healthy children and adolescents aged 1 month to 18 years), setting (first contact ambulatory care), outcome (serious infection), features assessed (in first contact care), and data reported (sufficient to construct a 2×2 table). DATA EXTRACTION: Quality assessment was based on the quality assessment tool of diagnostic accuracy studies (QUADAS) criteria. Meta-analyses were done using the bivariate random effects method and hierarchical summary receiver operating characteristic curves for studies with multiple thresholds. DATA SYNTHESIS: None of the 14 studies identified were of high methodological quality and all were carried out in an emergency department or paediatric assessment unit. The prevalence of serious infections ranged from 4.5% to 29.3%. Tests were carried out for C reactive protein (five studies), procalcitonin (three), erythrocyte sedimentation rate (one), interleukins (two), white blood cell count (seven), absolute neutrophil count (two), band count (three), and left shift (one). The tests providing most diagnostic value were C reactive protein and procalcitonin. Bivariate random effects meta-analysis (five studies, 1379 children) for C reactive protein yielded a pooled positive likelihood ratio of 3.15 (95% confidence interval 2.67 to 3.71) and a pooled negative likelihood ratio of 0.33 (0.22 to 0.49). To rule in serious infection, cut-off levels of 2 ng/mL for procalcitonin (two studies, positive likelihood ratio 13.7, 7.4 to 25.3 and 3.6, 1.4 to 8.9) and 80 mg/L for C reactive protein (one study, positive likelihood ratio 8.4, 5.1 to 14.1) are recommended; lower cut-off values of 0.5 ng/mL for procalcitonin or 20 mg/L for C reactive protein are necessary to rule out serious infection. White blood cell indicators are less valuable than inflammatory markers for ruling in serious infection (positive likelihood ratio 0.87-2.43), and have no value for ruling out serious infection (negative likelihood ratio 0.61-1.14). The best performing clinical decision rule (recently validated in an independent dataset) combines testing for C reactive protein, procalcitonin, and urinalysis and has a positive likelihood ratio of 4.92 (3.26 to 7.43) and a negative likelihood ratio of 0.07 (0.02 to 0.27).
CONCLUSION: Measuring inflammatory markers in an emergency department setting can be diagnostically useful, but clinicians should apply different cut-off values depending on whether they are trying to rule in or rule out serious infection. Measuring white blood cell count is less useful for ruling in serious infection and not useful for ruling out serious infection. More rigorous studies are needed, including studies in primary care, to assess the value of laboratory tests alongside clinical diagnostic measurements, including vital signs.

Entities:  

Mesh:

Year:  2011        PMID: 21653621     DOI: 10.1136/bmj.d3082

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  94 in total

1.  Use of laboratory tests in out-of-hours services in Norway.

Authors:  Ingrid Keilegavlen Rebnord; Hogne Sandvik; Steinar Hunskaar
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

2.  Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.

Authors:  Susanna Hernández-Bou; Borja Gómez; Santiago Mintegi; Juan J García-García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-07       Impact factor: 3.267

3.  In reply.

Authors:  Tim Niehues
Journal:  Dtsch Arztebl Int       Date:  2014-04-04       Impact factor: 5.594

4.  The Japanese guidelines for the management of sepsis.

Authors:  Shigeto Oda; Mayuki Aibiki; Toshiaki Ikeda; Hitoshi Imaizumi; Shigeatsu Endo; Ryoichi Ochiai; Joji Kotani; Nobuaki Shime; Osamu Nishida; Takayuki Noguchi; Naoyuki Matsuda; Hiroyuki Hirasawa
Journal:  J Intensive Care       Date:  2014-10-28

5.  Diagnostic uncertainty: dichotomies are not the answer.

Authors:  Bethany Shinkins; Rafael Perera
Journal:  Br J Gen Pract       Date:  2013-03       Impact factor: 5.386

6.  Use of alarm features in referral of febrile children to the emergency department: an observational study.

Authors:  Yvette van Ierland; Gijs Elshout; Henriëtte A Moll; Ruud G Nijman; Yvonne Vergouwe; Johan van der Lei; Marjolein Y Berger; Rianne Oostenbrink
Journal:  Br J Gen Pract       Date:  2014-01       Impact factor: 5.386

7.  Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.

Authors:  M Sato; H Nakasone; K Terasako-Saito; K Sakamoto; R Yamazaki; Y Tanaka; Y Akahoshi; H Nakano; T Ugai; H Wada; R Yamasaki; Y Ishihara; K Kawamura; M Ashizawa; S-i Kimura; M Kikuchi; A Tanihara; J Kanda; S Kako; J Nishida; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

8.  Is serum CRP level a reliable inflammatory marker in pediatric nephrotic syndrome?

Authors:  Eran Shostak; Irit Krause; Amit Dagan; Anat Ben-Dor; Meital Keidar; Miriam Davidovits
Journal:  Pediatr Nephrol       Date:  2016-03-08       Impact factor: 3.714

9.  The febrile child: diagnosis and treatment.

Authors:  Tim Niehues
Journal:  Dtsch Arztebl Int       Date:  2013-11-08       Impact factor: 5.594

10.  Validation of the Feverkidstool and procalcitonin for detecting serious bacterial infections in febrile children.

Authors:  Ruud G Nijman; Yvonne Vergouwe; Henriëtte A Moll; Frank J Smit; Floor Weerkamp; Ewout W Steyerberg; Johan van der Lei; Yolanda B de Rijke; Rianne Oostenbrink
Journal:  Pediatr Res       Date:  2017-11-08       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.